Repository logo
 
Publication

Blood pressure control and antihypertensive pharmacotherapy patterns in a hypertensive population of Eastern Central Region of Portugal

dc.contributor.authorMorgado, Manuel
dc.contributor.authorRolo, Sandra
dc.contributor.authorPereira, L.
dc.contributor.authorCastelo-Branco, Miguel
dc.date.accessioned2011-01-08T01:23:32Z
dc.date.available2011-01-08T01:23:32Z
dc.date.issued2010-12
dc.descriptionhttp://www.ncbi.nlm.nih.gov/pubmed/21192829por
dc.description.abstractBACKGROUND: Interventions to improve blood pressure control in hypertension have had limited success in clinical practice despite evidence of cardiovascular disease prevention in randomised controlled trials. The objectives of this study were to evaluate blood pressure control and antihypertensive pharmacotherapy patterns in a population of Eastern Central Region of Portugal, attending a hospital outpatient clinic (ambulatory setting) for routine follow-up. METHODS: Medical data of all patients that attended at least two medical appointments of hypertension / dyslipidemia in a university hospital over a one and a half year period (from January 2008 to June 2009) were retrospectively analysed. Demographic variables, clinical data and blood pressure values of hypertensive patients included in the study, as well as prescribing metrics were examined on a descriptive basis and expressed as the mean +/- SD, frequency and percentages. Student's test and Mann-Whitney rank sum test were used to compare continuous variables and chi-square test and Fisher exact probability test were used to test for differences between categorical variables. RESULTS: In all, 37% of hypertensive patients (n=76) had their blood pressure controlled according to international guidelines. About 45.5% of patients with a target blood pressure <140/90 mmHg (n=156) were controlled, whereas in patients with diabetes or chronic kidney disease (n=49) the corresponding figure was only 10.2% (P<0.001). Among patients initiating hypertension / dyslipidemia consultation within the study period 32.1% had stage 2 hypertension in the first appointment, but this figure decreased to 3.6% in the last consultation (P=0.012). Thiazide-type diuretics were the most prescribed antihypertensive drugs (67%) followed by angiotensin receptor blockers (60%) and beta-blockers (43%). About 95.9% patients with comorbid diabetes were treated with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker. CONCLUSIONS: Clinically important blood pressure decreases can be achieved soon after hypertension medical appointment initiation. However, many hypertensive patients prescribed with antihypertensive therapy fail to achieve blood pressure control in clinical practice, this control being worse among patients with diabetes or chronic kidney disease. As pharmacotherapy patterns seem to coincide with international guidelines, further research is needed to identify the causes of poor blood pressure control.por
dc.description.sponsorshipThis work was supported by Fundação para a Ciência e a Tecnologia (SFRH/BD/36756/2007) through a fellowship grant attributed to Manuel Morgado.por
dc.identifier.issn1472-6963
dc.identifier.otherDOI: 10.1186/1472-6963-10-349
dc.identifier.otherPMID: 21192829
dc.identifier.urihttp://hdl.handle.net/10400.6/657
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherJigisha Patel MRCP, PhDpor
dc.relation.ispartofseries2010 Dec 30;10(1):349;
dc.subjectHypertensionpor
dc.subjectBlood pressurepor
dc.subjectAntihypertensivespor
dc.subjectTreatmentpor
dc.subjectControlpor
dc.subjectPortugalpor
dc.titleBlood pressure control and antihypertensive pharmacotherapy patterns in a hypertensive population of Eastern Central Region of Portugalpor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleBMC Health Services Researchpor
person.familyNameNunes Vicente Passos Morgado
person.familyNamePereira
person.familyNameCASTELO-BRANCO CRAVEIRO SOUSA
person.givenNameManuel Augusto
person.givenNameLuísa
person.givenNameMIGUEL
person.identifierAAG-4910-2021
person.identifierF-7869-2010
person.identifier.ciencia-id7617-9FDC-2D9D
person.identifier.ciencia-id4F15-1868-D001
person.identifier.ciencia-idE91D-05E2-A2C1
person.identifier.orcid0000-0003-2112-2835
person.identifier.orcid0000-0002-9068-4607
person.identifier.orcid0000-0002-6191-5912
person.identifier.scopus-author-id55955252600
person.identifier.scopus-author-id10839238300
person.identifier.scopus-author-id36730721300
rcaap.rightsopenAccesspor
rcaap.typearticlepor
relation.isAuthorOfPublication7c614887-225f-44d4-b467-3cc34e44a98b
relation.isAuthorOfPublication604e508e-9f4e-4950-b2a4-1b06c7192afe
relation.isAuthorOfPublication67c51098-b7e8-4164-bcfe-528b50e11bfd
relation.isAuthorOfPublication.latestForDiscovery67c51098-b7e8-4164-bcfe-528b50e11bfd

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
JCDR-2-44.pdf
Size:
829.64 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: